SlideShare una empresa de Scribd logo
1 de 49
Descargar para leer sin conexión
CELL WALL
INHIBITORS
Chapter 31
By: Artina C. Aquitania
CELL WALL INHIBITORS
• Interfere with synthesis of the bacterial cell wall that is actively proliferating
• PEPTIDOGLYCAN- the cell wall of the bacteria composed of a polymer that consist
of glycan units joined to each other by peptide cross-links.
CELL WALL INHIBITORS
PENICILLINS
• Most widely effective antibiotics
• Least toxic drugs known, but INCREASED RESISTANCE has limited their use
• Differ from one another in the R substitute attached to the
6-aminopenicillanic acid residue
MECHANISM OF ACTION
• Interfere with the TRANSPEPTIDATION or cross-linkage, the LAST step of bacterial
synthesis, resulting to osmotically less stable membrane
• Cell lysis can then occur, either through osmotic pressure or activation of autolysins
• Thus, penicillins are BACTERICIDAL
• They are inactive against devoid of peptidoglycan structure, such as mycobacteria,
protozoa, fungi and viruses
1. Penicillin-binding proteins (PBPs)
- these do not only prevent cell wall synthesis but also lead to
morphologic changes or lysis of susceptible bacterial
- Alteration in some of these target molecules provide the organism with
resistance to the penicillins, such as Methicillin-resistant Staphylococcus aureus
(MRSA)
2. Inhibition of transpeptidase
- hinders the formation of cross-links essential for the cell wall integrity.
- as a result of this blockade of cell wall synthesis , the “Park nucleotide”
(formerly called “park peptide”), UDP-acetylmuramyl-L-Ala-D-Gln-L-Lys-D-Ala-D-
Ala, accumulates
3. Production of Autolysins
- In the presence of penicillins, the degradative action of the autolysins proceed in the
absence of cell wall synthesis.
- Inhibition of cell wall synthesis and destruction of existing cell wall by autolysis is the
antibacterial effect of penicillin.
MECHANISM OF ACTION 
ANTIBACTERIAL SPECTRUM
• Gram-positive microorganism have cell walls that are easily transversed by
penicillins
• Gram-negative microorganisms have an outer lipopolysaccharide membrane
(envelope) surrounding the cell wall that presents a barrier to the water-soluble
penicillins
• PORINS- proteins inserted in the lipopolysaccharide layer that act as water-filled
channels to permit transmembrane entry in gram-negative bacteria
• Pseudomonas aeruginosa- lacks porins
1. Natural penicillin
• classified as antistaphyloccocal
• Penicillin chrysogenum – obtained from the fermentation of mold
• Ampicillin – semisynthetic, 6-aminopenicillinic nucleus obtained from
fermentation broth of the mold
• Penicillin G (benzylpenicillin)- susceptible to inactivation of by B-
(penicillinases)
• Penicillin V (phenoxymethylpenicillin) – not used for treatment of
bacteremia because of its higher minimum bactericidal concentration
• - more acid-stable than penicillin G
2. Antistaphylococcal penicillins
• Methicillin, Nafcilin, Oxacillin, and Dicloxacillin – penicillanase-resistant
penicillins
• Their use is restricted to the treatment of infections caused by penicillinase-
producing staphylococci
• Because of its toxicity, methicillin is not used clinically except to identify
resistant strains of S. aureus
3. Extended-spectrum penicillins
• Ampicillin (Ampicin,Panacta) - have an antibacterial spectrum
similar to that of penicillin G but are more effective against gram
negative bacilli (AKA extended-spectrum penicillins)
- drug of choice for the gram-negatice bacillus
Listeria monocytogenes
- Widely used in the treatment of respiratory infections
• Amoxicillin – employed prophylactically by dentists for patients with
abnormal heart valve who are to undergo extensive oral surgery
4. Antipseudomonal penicillins
• Carbenicillin, piperacillin (Piptaz) – are called
antipseudomonal penicillins because of their activity
against P. aeruginosa
• Piperacillin (Peprasan T)- the most potent of these
antibiotics
- effective against any gram negative bacilli,
except klebsiella because of its constructive penicillinase
• Formulation of ticarcillin or piperacillin with clavunic acid
or tazobactam extends the antimicrobial spectrum of
these antibiotics to include penicillinase-producing
organisms
5. Penicillins and aminoglycosides
• The antibacterial effects of beta lactams antibiotics are synergistic with
aminoglycosides
• Cell wall synthesis inhibitors alter the permeability of bacterial cells,
these drugs can facilitate the entry of other antibiotics
• Although the combination of a penicillin plus an aminoglycoside is used
clinically, these drug types should never be placed in the same infusion
fluid, because on prolonged contact, the positively charged
aminoglycosides form an inactive complex with the negatively charged
penicillins
RESISTANCE
• Natural resistance to the penicillins occurs in organisms that either lack a
peptidoglycan cell wall or have cell walls that are impermeable to the drugs
• An organism may become resistant to several antibiotics at the same time due to
acquisition of a plasmid that encodes resistance to multiple agents
1. Beta lactamase activity - this family of enzymes hydrolyzes the
cyclic amide bond of the beta lactam ring, which results in bactericidal
activity
• Beta lactamases are either constitutive or more commonly are
by the transfer of plasmids
• Certain organisms may have chromosome-associated beta lactamase
that are inducible by beta lactam antibiotics (e.g cefoxitin). Gram
positive organisms secrete beta lactamase extracellularly, whereas
negative bacteria confine the enzymes in the periplasmic space
between the inner and outer membranes.
2. Decreased permeability to the drug – decreased penetration of
the antibiotic through the outer cell membrane prevents the drug from
reaching PBPs
• The presence of efflux pump can also reduce the amount of
drug
3. Altered PBPs – modified PBPs have a lower affinity for beta lactam
antibiotics, requiring clinically unattainable concentrations of the drug to
effect inhibition of bacterial growth
PHARMAKOKINETICS
1. Administration – the route of administration of a beta lactam antibiotic is
determined by the stability of the drug to gastric acid and by the severity
of the infection
• Routes of administration- Ticarcillin, carbenicillin, piperacillin, and the
combinations of ampicillin with sulbactam, ticarcillin with clavunic acid and
piperacillin with tazobactam , must be administered intravenously (IV) or
intramuscularly (IM); Penicillin V, amoxicillin combined with clavunic acid and
the indanyl ester of carbenicillin are available as oral preparations
• Depot forms – Procaine penicillin G and Benzathine penicillin G are
administered IM and serve as depot forms. They are slowly absorbed into
the circulation and persist at low levels over a long time period
-
2. Absorption- most of the penicillins are incompletely
absorbed after oral administration, and they reach the
intestine in sufficient amounts to affect the composition in
sufficient amounts to affect the compositionof the intestinal
flora
- however amoxicillin, is completely absorbed
- absorption of all the penicillinase-resistant penicillins
is decreased by food in the stomach, because gastric
emptying time is lengthened, and the drugs are destroyed in
the acidic environment (should be administered 30-60
minutes before meals or 2-3 hours postprandially)
3. Distribution – the beta lactam antibiotics distribute well
throughout the body
- all the penicillins cross the placental barrier, but none
has been shown to be teratogenic,
- during the acute phase of infection, the inflamed
meninges are more permeable to the penicillins, resulting in an
increased ratio of the amount of drug in the central nervous
system compared to the amount of drug in the CNS compared
to the amount in the serum
- penicillin levels in the prostate are insufficient to be
effective against infections
4. Metabolism- host metabolism of the beta lactam antibiotics is usually
insignificant, but some metabolism of Penicillin G has been shown to
occur in patients with impaired renal function
5. Excretion – primary route of excretion: organic acid (tubular)
secretory system and glomerular filtration
- the half-life of penicillin G can increase from normal of between 30
minutes and 1 hour, to 10 hours in individuals with renal failure
- Probenecid inhibits the excretion of penicillins by competing for
active tubular secretion via the organic acid transporter and, thus can
increase blood levels.
- Nafcillin is eliminated primarily though the biliary route
- Penicillins are also excreted in breast milk
ADVERSE REACTIONS
• 1. Hypersensitivity – most important adverse effect of the
penicillins.
• - the major antigenic determinant of penicillin hypersensitivity is its metabolite, penicilloic acid
which reacts with proteins and serves as a hapten to cause an immune reaction
• 2. Diarrhea – caused by a disruption of the normal balance of
intestinal microorganism
• - it occurs to a greater extent with those agents that are incompletely absorbed and have an
extended antibacterial spectrum
• 3. Nephritis – all penicillins but particularly methicillin,
have the potential to cause acute interstitial nephritis
• 4. Neurotoxicity – the penicillins are irritating to neuronal
tissue, and they can provoke seizures
• 5. Hematologic toxicities- decreased coagulation may be
observed with the antipseudomonal penicillins
(carbenicillin and ticarcillin) and to some extent penicillin
G
• - additional toxicities include eosinophilia
• 6. Cation toxicity – penicillins are
generally administered as the sodium or
potassium salt.
• - toxicities may be caused by the large
quantities of sodium or potassium that
accompany the penicillin
CEPHALOSPORINS
• The cephalosporins are beta lactam antibiotics that are closely related both
structurally and functionally to the penicillins
• They have the same mode of actions of penicillins, and they are affected by the
same resistance mechanisms
• They tend to be more resistant than the penicillins to certain beta lactamases
CEPHALOSPORINS
• 5th Gen
• Ceftobiprole (Teflaro)
• Ceftaroline(Zeftera)
• 1st Gen
• Cefadroxil
• Cefazolin (Ilozef)
• Cephalexin (Cefalin/Ivynall)
• Cefalotin
• Ceftradine
• 2nd Gen
• Cefaclor (Ceclor)
• Cefprozil
• Cefuroxime (Cefurex)
• Cefoxitin
• Cefamandole
• Cefmetazole
• Lefotiam
• 3rd Gen
• Cefdinir
• Cefixime
• Cefotaxime
• Ceftazidime
• Ceftibuten
• Ceftizoxime
• Ceftriaxone (Keptrix)
• Cefoperazone
• Cefpodoxime
• 4th Gen
• Cefipime (Polyzef)
• Cefpirome
ANTIBACTERIAL SPECTRUM
• They have been classified as 1st, 2nd, 3rd, 4th and 5th generation,
based largely on their bacterial susceptibility patterns and
resistance to beta lactamase
• Ineffective against MRSA, L. monocytogenes, Clostridium
difficile, and the enterococci
• First generation – act as penicillin G substitutes
• - resistant to Staphylococcal penicillinase and
also have activity against Proteus mirabillis, E.
Coli, and Klebsiella pneumoniae
• Second generation – display greater activity against
three additional gram negative organisms: H. influenza,
Enterobacter aerogenes and some Neisseria species,
whereas activity against gram positive organisms is
weaker
• Third generation – assumed an important role in the treatment of
infectious disease
• - inferior to first-generation cephalosporins in regard to
their activity against gram positive cocci, the third-
generation cephalosporins have enhanced activity
gram negative bacilli
• Fourth generation – Cefepime – is classified as fourth generation and
must be administered parenterally
• - effective against aerobic gram negative
organisms such as Enterobater, E. coli, K.
pneumonia, P. mirabilis, P, aeruginosa
RESISTANCE
• Mechanisms of bacterial resistance to the cephalosporins are essentially the same
sas those described for the penicillins
• 5th generation – Ceftobiprole can be distinguished from other beta lactams by its
increased binding to penicillin-binding protein 2a, enzyme most directly related to
methicillin-resistant staphylococci
• Coverage is from gram negative to gram positives, MRSA and including Pseudomonas
species
• Against both the community acquired MRSA strains and hospital-acquired MRSA strains
PHARMAKOKINETICS
• Administration
• Cephalosporins are administered IM or IV because of their poor oral absorption
• Distributions
• Cephalosporins distribute very well into the body fluids
• Ceftriaxone or cefoxatime are effective in the treatment of neonatal and childhood
meningitis caused by H. influenza
• Cefazolin finds application as a single prophylaxis dose prior to surgery because of its
1.8 hour half-life and its activity against penicillinase-producing S. aureus
• Fate
• Elimination occurs though tubular secretion and/or glomerular filtration
• Doses must be adjusted in cases of severe renal failure to guard against
accumulation and toxicity
• Ceftriaxone is excreted through the bile into the feces and, therefore is
frequently employed in patients with renal insufficiency
• Adverse effects
• Allergic manifestations – patients who have had anaphylactic reponse to
penicillins should not receive cephalosporins
OTHER BETA LACTAM ANTIBIOTICS
• Carbapenems- synthetic beta lactam antibiotics that differ in structure from the
penicillins in that the sulfur atom of the thiazolidine ring has been externalized and
replaced by a carbon atom
• Imipenem, Meropinem and Ertapenem are the only drugs of this group currently
available
• Imipenem is compounded with cilastatin to protect it from metabolism by renal
dehydropeptidase
ANTIBACTERIAL SPECTRUM
• Imipinem/cilastatin and meropenem are the broadest spectrum beta lactam
antibiotic preparations currently available
• Imipenem (Tienam,Plastin)- resists hydrolysis by most beta lactamases, but not
metallo-beta lactamases
• Meropenem (Merop) has antibacterial activity similar to that of imipenem
• Ertapenem is not an alternative for P. aeruginosa coverage, because most exhibit
resistance
PHARMAKOKINETICS
• Imipenem and meropenem are administered IV and penetrate well into
body tissues and fluids, including the CSF when the minges are inflamed.
They are excreted through glomerular filtration
• Imipenem undergoes cleavage by by dehydropeptidase found in the
brush border of the proximal renal tubule
• Compounding the imipenem with cilastatin protects the parent drug
and, thus, prevents the formation of the toxic metabolite
• Meropenem does not undergo metabolism
• Ertapenem can be administeres via IV or IM
ADVERSE AFFECTS
• Imipenem/cilastatin can cause nausea, vomiting and diarrhea
• Eosinophilia and neutropenia are less common than with other beta lactams
MONOBACTAMS
• The monobactams, which also disrupt bacterial cell wall synthesis, are unique,
because the B-lactam ring is not fused to another ring.
• Aztreonam (Aztram), which is the only commercially available monobactam, has
antimicrobial activity directed primarily against the enterobacteriaceae, but also acts
against aerobic gram-negative rods, including P. aeruginosa.
B-LACTAMASE INHIBITORS
• Hydrolysis of the B-lactam ring, either by enzymatic cleavage with a B-lactamase or
by acid, destroys the antimicrobial activity of a B-lactam antibiotic.
• B-Lactamase inhibitors, such as clavulanic acid, sulbactam, and tazobactam, contain
a B-lactam ring but, by themselves, do not have significant antibacterial activity.
VANCOMYCIN
• Vancomycin is a tricyclic glycopeptide that has become increasingly important
because of it effectiveness against multiple drug-resistant organisms, such as MRSA
and enterococci.
MODE OF ACTION
• Vancomycin inhibits synthesis of bacterial cell wall phospholipids as well as
peptidoglycan polymerization by binding to the D-Ala-D-Ala side chain of the
precursor pentapeptide. This prevents the transglycosylation step in peptidoglycan
polymerization, thus weakening the cell wall and damaging the underlying cell
membrane.
ANTIBACTERIAL SPECTRUM
• Vancomycin is effective primarily against gram-positive organisms. It has been
lifesaving in the treatment of MRSA and methicillin-resistant Staphylococcus
epidermidis infections as well as enterococcal infections.
RESISTANCE
• Vancomycin resistance can be caused by plasmid-mediated change in permeability
to the drug or by decreased binding of vancomycin to receptor molecules.
PHARMACOKINETICS
• Slow IV infusion is employed for treatment of systemic infections or for prophylaxis.
Because vancomycin is not absorbed after oral administration, this route is
employed only for the treatment of antibiotic-induced colitis due to C. difficile when
metronidazole has proven to be ineffective.
• Inflammation allows penetration into the meninges.
ADVERSE EFFECTS
• Side effects are a serious problem with vancomycin and include fever, chills, and/or
phlebitis at the infusion site.
• Flushing and shock results from histamine release associated with a rapid infusion.
DAPTOMYCIN
• Daptomycin is a cyclic lipopeptide antibiotic that is an alternative to other agents,
such as linezolid and quinupristin/ dalfopristin, for treating infections caused by
resistant gram-positive organisms, including MRSA and vancomycin-resistant
enterococci.
MODE OF ACTION
• Upon binding to the bacterial cytoplasmic membrane, daptomycin induces rapid
depolarization of the membrane, thus disrupting multiple aspects of membrane
function and inhibiting intracellular synthesis of DNA, RNA, and protein.
• Daptomycin is bactericidal, and bacterial killing is concentration dependent.
ANTIBACTERIAL SPECTRUM
• Daptomycin has a spectrum of activity limited to gram-positive organisms, which
includes methicillin-susceptible and methicillin-resistant S.aureus, penicillin-resistant
Streptococcus pneumonia, Streptococcus pyogenes, Corynebacterium jeikeium,
E. faecalis, and E. faecium.
PHARMACOKINETICS
• Daptomycin is 90 to 95 percent protein bound and does not appear to undergo
hepatic metabolism; however, the dosing interval needs to be adjusted in patients
with renal impairment.
• In skin and soft tissue infections, daptomycin is administered at 4 mg/kg IV daily via
a 30-minute infusion. Nevertheless, when treating bacteremia and endocarditis,
dose should be increased to 6 mg/kg.
ADVERSE EFFECTS
• The most common adverse effects reported in clinical trials included constipation,
nausea, headache, and insomnia.
• Increased hepatic transaminases and also elevations in creatin phosphokinases
occurred, suggesting weekly monitoring while the patient is receiving daptomycin.

Más contenido relacionado

La actualidad más candente

Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibioticsEneutron
 
Pharmacology - Cell wall inhibitors 2
Pharmacology  - Cell wall inhibitors 2Pharmacology  - Cell wall inhibitors 2
Pharmacology - Cell wall inhibitors 2Areej Abu Hanieh
 
Antibacterial agents
Antibacterial agentsAntibacterial agents
Antibacterial agentsTouheed Ovi
 
Beta lactam antibiotics (penicillins and cephalosporins)
Beta lactam antibiotics (penicillins and cephalosporins)Beta lactam antibiotics (penicillins and cephalosporins)
Beta lactam antibiotics (penicillins and cephalosporins)JABEEN FATIMA
 
Antibiotics acting on cell wall 3 Carbapenems and Monobactums 03-05-2018
Antibiotics acting on cell wall 3   Carbapenems and Monobactums 03-05-2018Antibiotics acting on cell wall 3   Carbapenems and Monobactums 03-05-2018
Antibiotics acting on cell wall 3 Carbapenems and Monobactums 03-05-2018Ravi Kant Agrawal
 
Pharmacology of Semi synthetic Penicillins
Pharmacology of Semi synthetic Penicillins Pharmacology of Semi synthetic Penicillins
Pharmacology of Semi synthetic Penicillins Vijay Kevlani
 
Chapter-Beta lactamase inhibitors
Chapter-Beta lactamase inhibitorsChapter-Beta lactamase inhibitors
Chapter-Beta lactamase inhibitorsAnjali Bhardwaj
 
Antimicrobial therapy-General consideration
Antimicrobial therapy-General considerationAntimicrobial therapy-General consideration
Antimicrobial therapy-General considerationPravin Prasad
 
Pharmacology -Protein synthesis inhibitors 2
Pharmacology -Protein synthesis inhibitors 2Pharmacology -Protein synthesis inhibitors 2
Pharmacology -Protein synthesis inhibitors 2Areej Abu Hanieh
 

La actualidad más candente (20)

2.ANTIBIOTIC (CELL WALL INHIBITORS)
2.ANTIBIOTIC (CELL WALL INHIBITORS)2.ANTIBIOTIC (CELL WALL INHIBITORS)
2.ANTIBIOTIC (CELL WALL INHIBITORS)
 
Beta lactam antibiotics
Beta lactam antibioticsBeta lactam antibiotics
Beta lactam antibiotics
 
Pharmacology - Cell wall inhibitors 2
Pharmacology  - Cell wall inhibitors 2Pharmacology  - Cell wall inhibitors 2
Pharmacology - Cell wall inhibitors 2
 
Carbapenems
CarbapenemsCarbapenems
Carbapenems
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Beta lactam Antibiotics
Beta lactam AntibioticsBeta lactam Antibiotics
Beta lactam Antibiotics
 
Penicillin
PenicillinPenicillin
Penicillin
 
Penicillins
PenicillinsPenicillins
Penicillins
 
Antibacterial agents
Antibacterial agentsAntibacterial agents
Antibacterial agents
 
Beta lactam antibiotics (penicillins and cephalosporins)
Beta lactam antibiotics (penicillins and cephalosporins)Beta lactam antibiotics (penicillins and cephalosporins)
Beta lactam antibiotics (penicillins and cephalosporins)
 
Antibiotics acting on cell wall 3 Carbapenems and Monobactums 03-05-2018
Antibiotics acting on cell wall 3   Carbapenems and Monobactums 03-05-2018Antibiotics acting on cell wall 3   Carbapenems and Monobactums 03-05-2018
Antibiotics acting on cell wall 3 Carbapenems and Monobactums 03-05-2018
 
Antibiotic types and mechanism of action
Antibiotic types and mechanism of actionAntibiotic types and mechanism of action
Antibiotic types and mechanism of action
 
Pencilins
PencilinsPencilins
Pencilins
 
Pharmacology of Semi synthetic Penicillins
Pharmacology of Semi synthetic Penicillins Pharmacology of Semi synthetic Penicillins
Pharmacology of Semi synthetic Penicillins
 
Chapter-Beta lactamase inhibitors
Chapter-Beta lactamase inhibitorsChapter-Beta lactamase inhibitors
Chapter-Beta lactamase inhibitors
 
Antibiotics
Antibiotics Antibiotics
Antibiotics
 
Antibacterial drugs
Antibacterial drugsAntibacterial drugs
Antibacterial drugs
 
Antimicrobial therapy-General consideration
Antimicrobial therapy-General considerationAntimicrobial therapy-General consideration
Antimicrobial therapy-General consideration
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Pharmacology -Protein synthesis inhibitors 2
Pharmacology -Protein synthesis inhibitors 2Pharmacology -Protein synthesis inhibitors 2
Pharmacology -Protein synthesis inhibitors 2
 

Destacado

Cell wall synthesis inhibitors
Cell wall synthesis inhibitorsCell wall synthesis inhibitors
Cell wall synthesis inhibitorsDr.Reshmi Sameeth
 
Antibacterials summary by Laith Yahya
Antibacterials summary by Laith YahyaAntibacterials summary by Laith Yahya
Antibacterials summary by Laith Yahyalaithreal
 
Morphoofbacteria 110725164319-phpapp01
Morphoofbacteria 110725164319-phpapp01Morphoofbacteria 110725164319-phpapp01
Morphoofbacteria 110725164319-phpapp01Lucas Ampaire
 
Bls 107 general microbiology
Bls 107 general microbiologyBls 107 general microbiology
Bls 107 general microbiologyBruno Mmassy
 
Bacterial Structures
Bacterial StructuresBacterial Structures
Bacterial StructuresElysia Butler
 
CPR2010 ACLS
CPR2010 ACLSCPR2010 ACLS
CPR2010 ACLSzybernav
 
Module 2 bacterial cytology & physiology
Module 2 bacterial cytology & physiologyModule 2 bacterial cytology & physiology
Module 2 bacterial cytology & physiologyRaniagaye Mansibang
 
Amol&suraj ppt penicillin
Amol&suraj ppt penicillinAmol&suraj ppt penicillin
Amol&suraj ppt penicillinAmol Pawar
 
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Pavan Kumar
 
Costipation..ppt4
Costipation..ppt4Costipation..ppt4
Costipation..ppt4Amol Pawar
 

Destacado (20)

Beta lactams, protein sythesis inhibitors, other antibiotics 1-suman nizam.ii...
Beta lactams, protein sythesis inhibitors, other antibiotics 1-suman nizam.ii...Beta lactams, protein sythesis inhibitors, other antibiotics 1-suman nizam.ii...
Beta lactams, protein sythesis inhibitors, other antibiotics 1-suman nizam.ii...
 
Cell wall synthesis inhibitors
Cell wall synthesis inhibitorsCell wall synthesis inhibitors
Cell wall synthesis inhibitors
 
Antibiotics ppt
Antibiotics pptAntibiotics ppt
Antibiotics ppt
 
Antibacterials summary by Laith Yahya
Antibacterials summary by Laith YahyaAntibacterials summary by Laith Yahya
Antibacterials summary by Laith Yahya
 
Morphoofbacteria 110725164319-phpapp01
Morphoofbacteria 110725164319-phpapp01Morphoofbacteria 110725164319-phpapp01
Morphoofbacteria 110725164319-phpapp01
 
Bls 107 general microbiology
Bls 107 general microbiologyBls 107 general microbiology
Bls 107 general microbiology
 
Antibiotics Lecture 03
Antibiotics Lecture 03Antibiotics Lecture 03
Antibiotics Lecture 03
 
Bacterial Structures
Bacterial StructuresBacterial Structures
Bacterial Structures
 
Morphologyy
MorphologyyMorphologyy
Morphologyy
 
Taxonomy of bacteria
Taxonomy of bacteriaTaxonomy of bacteria
Taxonomy of bacteria
 
CPR2010 ACLS
CPR2010 ACLSCPR2010 ACLS
CPR2010 ACLS
 
Module 2 bacterial cytology & physiology
Module 2 bacterial cytology & physiologyModule 2 bacterial cytology & physiology
Module 2 bacterial cytology & physiology
 
Amol&suraj ppt penicillin
Amol&suraj ppt penicillinAmol&suraj ppt penicillin
Amol&suraj ppt penicillin
 
Microbiology
Microbiology Microbiology
Microbiology
 
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
 
3. pencillin
3. pencillin3. pencillin
3. pencillin
 
Costipation..ppt4
Costipation..ppt4Costipation..ppt4
Costipation..ppt4
 
streptogramin final
streptogramin finalstreptogramin final
streptogramin final
 
Penicillins
PenicillinsPenicillins
Penicillins
 
Aquaporins
Aquaporins Aquaporins
Aquaporins
 

Similar a Cell wall inhibitors

Cell wall inhibitors and Beta lactum antibiotics
Cell wall inhibitors and Beta lactum antibioticsCell wall inhibitors and Beta lactum antibiotics
Cell wall inhibitors and Beta lactum antibioticsMuhammad Amir Sohail
 
Beta lactam antibiotics - penicillins
Beta lactam antibiotics - penicillinsBeta lactam antibiotics - penicillins
Beta lactam antibiotics - penicillinsAshok Kumar
 
Beta lactam antibiotics (penicillins)
Beta lactam antibiotics (penicillins)Beta lactam antibiotics (penicillins)
Beta lactam antibiotics (penicillins)BAVAMH
 
penicillin drug classification and side effects
penicillin drug classification and side effectspenicillin drug classification and side effects
penicillin drug classification and side effectsShansub1
 
Mode of action of penicillin
Mode of action of penicillin Mode of action of penicillin
Mode of action of penicillin ShubhamDubey217
 
Penicillin ppt, pharmacology, presentation
Penicillin ppt, pharmacology, presentationPenicillin ppt, pharmacology, presentation
Penicillin ppt, pharmacology, presentationHariSadu6
 
Antibiotics and analgesics in pediatric dentistry
Antibiotics and analgesics in pediatric dentistryAntibiotics and analgesics in pediatric dentistry
Antibiotics and analgesics in pediatric dentistryParikshit Kadam
 
2. PHARMACOLOGY II.pdf
2. PHARMACOLOGY II.pdf2. PHARMACOLOGY II.pdf
2. PHARMACOLOGY II.pdfKeyaArere
 
Anti-infective agents1.ppt
Anti-infective agents1.pptAnti-infective agents1.ppt
Anti-infective agents1.pptAmosLangat5
 
Beta lactam inhibitors (1) (1).pptx
Beta lactam inhibitors (1) (1).pptxBeta lactam inhibitors (1) (1).pptx
Beta lactam inhibitors (1) (1).pptxKeyaArere
 
Beta-lactam antibiotics.pptx
Beta-lactam antibiotics.pptxBeta-lactam antibiotics.pptx
Beta-lactam antibiotics.pptxyogesh532361
 
Beta lactams- History, Current Trend and Recent Advances
Beta  lactams- History, Current Trend and Recent AdvancesBeta  lactams- History, Current Trend and Recent Advances
Beta lactams- History, Current Trend and Recent AdvancesAnkitaNegi32
 
Cell wall inhibitors
Cell wall inhibitors Cell wall inhibitors
Cell wall inhibitors Rawan Adnan
 
animicrobial drugs.pptx
animicrobial drugs.pptxanimicrobial drugs.pptx
animicrobial drugs.pptxTasneem Ali
 
ANTIBIOTICS-1.ppt
ANTIBIOTICS-1.pptANTIBIOTICS-1.ppt
ANTIBIOTICS-1.pptAlick12
 

Similar a Cell wall inhibitors (20)

Cell wall inhibitors and Beta lactum antibiotics
Cell wall inhibitors and Beta lactum antibioticsCell wall inhibitors and Beta lactum antibiotics
Cell wall inhibitors and Beta lactum antibiotics
 
Antibiotics
Antibiotics Antibiotics
Antibiotics
 
Beta lactam antibiotics - penicillins
Beta lactam antibiotics - penicillinsBeta lactam antibiotics - penicillins
Beta lactam antibiotics - penicillins
 
Beta lactam antibiotics (penicillins)
Beta lactam antibiotics (penicillins)Beta lactam antibiotics (penicillins)
Beta lactam antibiotics (penicillins)
 
penicillin drug classification and side effects
penicillin drug classification and side effectspenicillin drug classification and side effects
penicillin drug classification and side effects
 
Mode of action of penicillin
Mode of action of penicillin Mode of action of penicillin
Mode of action of penicillin
 
antimicrobials -1.pptx
antimicrobials -1.pptxantimicrobials -1.pptx
antimicrobials -1.pptx
 
Penicillin ppt, pharmacology, presentation
Penicillin ppt, pharmacology, presentationPenicillin ppt, pharmacology, presentation
Penicillin ppt, pharmacology, presentation
 
Beta Lactams.pptx
Beta Lactams.pptxBeta Lactams.pptx
Beta Lactams.pptx
 
Antibiotics and analgesics in pediatric dentistry
Antibiotics and analgesics in pediatric dentistryAntibiotics and analgesics in pediatric dentistry
Antibiotics and analgesics in pediatric dentistry
 
2. PHARMACOLOGY II.pdf
2. PHARMACOLOGY II.pdf2. PHARMACOLOGY II.pdf
2. PHARMACOLOGY II.pdf
 
Anti-infective agents1.ppt
Anti-infective agents1.pptAnti-infective agents1.ppt
Anti-infective agents1.ppt
 
Cell wall.pptx
Cell wall.pptxCell wall.pptx
Cell wall.pptx
 
Beta lactam inhibitors (1) (1).pptx
Beta lactam inhibitors (1) (1).pptxBeta lactam inhibitors (1) (1).pptx
Beta lactam inhibitors (1) (1).pptx
 
Beta-lactam antibiotics.pptx
Beta-lactam antibiotics.pptxBeta-lactam antibiotics.pptx
Beta-lactam antibiotics.pptx
 
Beta lactams- History, Current Trend and Recent Advances
Beta  lactams- History, Current Trend and Recent AdvancesBeta  lactams- History, Current Trend and Recent Advances
Beta lactams- History, Current Trend and Recent Advances
 
Cell wall inhibitors
Cell wall inhibitors Cell wall inhibitors
Cell wall inhibitors
 
animicrobial drugs.pptx
animicrobial drugs.pptxanimicrobial drugs.pptx
animicrobial drugs.pptx
 
Antibiotic ppt
Antibiotic pptAntibiotic ppt
Antibiotic ppt
 
ANTIBIOTICS-1.ppt
ANTIBIOTICS-1.pptANTIBIOTICS-1.ppt
ANTIBIOTICS-1.ppt
 

Último

How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17Celine George
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptxSandy Millin
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxDr. Santhosh Kumar. N
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxEduSkills OECD
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapitolTechU
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice documentXsasf Sfdfasd
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesMohammad Hassany
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesCeline George
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphNetziValdelomar1
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxKatherine Villaluna
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfMohonDas
 
Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...raviapr7
 

Último (20)

How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17How to Make a Field read-only in Odoo 17
How to Make a Field read-only in Odoo 17
 
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
2024.03.23 What do successful readers do - Sandy Millin for PARK.pptx
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptx
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptx
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice document
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming Classes
 
How to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 SalesHow to Manage Cross-Selling in Odoo 17 Sales
How to Manage Cross-Selling in Odoo 17 Sales
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
Presentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a ParagraphPresentation on the Basics of Writing. Writing a Paragraph
Presentation on the Basics of Writing. Writing a Paragraph
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 
UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024UKCGE Parental Leave Discussion March 2024
UKCGE Parental Leave Discussion March 2024
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdf
 
Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...
 

Cell wall inhibitors

  • 2. CELL WALL INHIBITORS • Interfere with synthesis of the bacterial cell wall that is actively proliferating • PEPTIDOGLYCAN- the cell wall of the bacteria composed of a polymer that consist of glycan units joined to each other by peptide cross-links.
  • 4. PENICILLINS • Most widely effective antibiotics • Least toxic drugs known, but INCREASED RESISTANCE has limited their use • Differ from one another in the R substitute attached to the 6-aminopenicillanic acid residue
  • 5. MECHANISM OF ACTION • Interfere with the TRANSPEPTIDATION or cross-linkage, the LAST step of bacterial synthesis, resulting to osmotically less stable membrane • Cell lysis can then occur, either through osmotic pressure or activation of autolysins • Thus, penicillins are BACTERICIDAL • They are inactive against devoid of peptidoglycan structure, such as mycobacteria, protozoa, fungi and viruses
  • 6. 1. Penicillin-binding proteins (PBPs) - these do not only prevent cell wall synthesis but also lead to morphologic changes or lysis of susceptible bacterial - Alteration in some of these target molecules provide the organism with resistance to the penicillins, such as Methicillin-resistant Staphylococcus aureus (MRSA) 2. Inhibition of transpeptidase - hinders the formation of cross-links essential for the cell wall integrity. - as a result of this blockade of cell wall synthesis , the “Park nucleotide” (formerly called “park peptide”), UDP-acetylmuramyl-L-Ala-D-Gln-L-Lys-D-Ala-D- Ala, accumulates
  • 7. 3. Production of Autolysins - In the presence of penicillins, the degradative action of the autolysins proceed in the absence of cell wall synthesis. - Inhibition of cell wall synthesis and destruction of existing cell wall by autolysis is the antibacterial effect of penicillin.
  • 9. ANTIBACTERIAL SPECTRUM • Gram-positive microorganism have cell walls that are easily transversed by penicillins • Gram-negative microorganisms have an outer lipopolysaccharide membrane (envelope) surrounding the cell wall that presents a barrier to the water-soluble penicillins • PORINS- proteins inserted in the lipopolysaccharide layer that act as water-filled channels to permit transmembrane entry in gram-negative bacteria • Pseudomonas aeruginosa- lacks porins
  • 10. 1. Natural penicillin • classified as antistaphyloccocal • Penicillin chrysogenum – obtained from the fermentation of mold • Ampicillin – semisynthetic, 6-aminopenicillinic nucleus obtained from fermentation broth of the mold • Penicillin G (benzylpenicillin)- susceptible to inactivation of by B- (penicillinases) • Penicillin V (phenoxymethylpenicillin) – not used for treatment of bacteremia because of its higher minimum bactericidal concentration • - more acid-stable than penicillin G
  • 11. 2. Antistaphylococcal penicillins • Methicillin, Nafcilin, Oxacillin, and Dicloxacillin – penicillanase-resistant penicillins • Their use is restricted to the treatment of infections caused by penicillinase- producing staphylococci • Because of its toxicity, methicillin is not used clinically except to identify resistant strains of S. aureus
  • 12. 3. Extended-spectrum penicillins • Ampicillin (Ampicin,Panacta) - have an antibacterial spectrum similar to that of penicillin G but are more effective against gram negative bacilli (AKA extended-spectrum penicillins) - drug of choice for the gram-negatice bacillus Listeria monocytogenes - Widely used in the treatment of respiratory infections • Amoxicillin – employed prophylactically by dentists for patients with abnormal heart valve who are to undergo extensive oral surgery
  • 13. 4. Antipseudomonal penicillins • Carbenicillin, piperacillin (Piptaz) – are called antipseudomonal penicillins because of their activity against P. aeruginosa • Piperacillin (Peprasan T)- the most potent of these antibiotics - effective against any gram negative bacilli, except klebsiella because of its constructive penicillinase • Formulation of ticarcillin or piperacillin with clavunic acid or tazobactam extends the antimicrobial spectrum of these antibiotics to include penicillinase-producing organisms
  • 14. 5. Penicillins and aminoglycosides • The antibacterial effects of beta lactams antibiotics are synergistic with aminoglycosides • Cell wall synthesis inhibitors alter the permeability of bacterial cells, these drugs can facilitate the entry of other antibiotics • Although the combination of a penicillin plus an aminoglycoside is used clinically, these drug types should never be placed in the same infusion fluid, because on prolonged contact, the positively charged aminoglycosides form an inactive complex with the negatively charged penicillins
  • 15. RESISTANCE • Natural resistance to the penicillins occurs in organisms that either lack a peptidoglycan cell wall or have cell walls that are impermeable to the drugs • An organism may become resistant to several antibiotics at the same time due to acquisition of a plasmid that encodes resistance to multiple agents
  • 16. 1. Beta lactamase activity - this family of enzymes hydrolyzes the cyclic amide bond of the beta lactam ring, which results in bactericidal activity • Beta lactamases are either constitutive or more commonly are by the transfer of plasmids • Certain organisms may have chromosome-associated beta lactamase that are inducible by beta lactam antibiotics (e.g cefoxitin). Gram positive organisms secrete beta lactamase extracellularly, whereas negative bacteria confine the enzymes in the periplasmic space between the inner and outer membranes.
  • 17. 2. Decreased permeability to the drug – decreased penetration of the antibiotic through the outer cell membrane prevents the drug from reaching PBPs • The presence of efflux pump can also reduce the amount of drug 3. Altered PBPs – modified PBPs have a lower affinity for beta lactam antibiotics, requiring clinically unattainable concentrations of the drug to effect inhibition of bacterial growth
  • 18. PHARMAKOKINETICS 1. Administration – the route of administration of a beta lactam antibiotic is determined by the stability of the drug to gastric acid and by the severity of the infection • Routes of administration- Ticarcillin, carbenicillin, piperacillin, and the combinations of ampicillin with sulbactam, ticarcillin with clavunic acid and piperacillin with tazobactam , must be administered intravenously (IV) or intramuscularly (IM); Penicillin V, amoxicillin combined with clavunic acid and the indanyl ester of carbenicillin are available as oral preparations • Depot forms – Procaine penicillin G and Benzathine penicillin G are administered IM and serve as depot forms. They are slowly absorbed into the circulation and persist at low levels over a long time period -
  • 19. 2. Absorption- most of the penicillins are incompletely absorbed after oral administration, and they reach the intestine in sufficient amounts to affect the composition in sufficient amounts to affect the compositionof the intestinal flora - however amoxicillin, is completely absorbed - absorption of all the penicillinase-resistant penicillins is decreased by food in the stomach, because gastric emptying time is lengthened, and the drugs are destroyed in the acidic environment (should be administered 30-60 minutes before meals or 2-3 hours postprandially)
  • 20. 3. Distribution – the beta lactam antibiotics distribute well throughout the body - all the penicillins cross the placental barrier, but none has been shown to be teratogenic, - during the acute phase of infection, the inflamed meninges are more permeable to the penicillins, resulting in an increased ratio of the amount of drug in the central nervous system compared to the amount of drug in the CNS compared to the amount in the serum - penicillin levels in the prostate are insufficient to be effective against infections
  • 21. 4. Metabolism- host metabolism of the beta lactam antibiotics is usually insignificant, but some metabolism of Penicillin G has been shown to occur in patients with impaired renal function 5. Excretion – primary route of excretion: organic acid (tubular) secretory system and glomerular filtration - the half-life of penicillin G can increase from normal of between 30 minutes and 1 hour, to 10 hours in individuals with renal failure - Probenecid inhibits the excretion of penicillins by competing for active tubular secretion via the organic acid transporter and, thus can increase blood levels. - Nafcillin is eliminated primarily though the biliary route - Penicillins are also excreted in breast milk
  • 22. ADVERSE REACTIONS • 1. Hypersensitivity – most important adverse effect of the penicillins. • - the major antigenic determinant of penicillin hypersensitivity is its metabolite, penicilloic acid which reacts with proteins and serves as a hapten to cause an immune reaction • 2. Diarrhea – caused by a disruption of the normal balance of intestinal microorganism • - it occurs to a greater extent with those agents that are incompletely absorbed and have an extended antibacterial spectrum
  • 23. • 3. Nephritis – all penicillins but particularly methicillin, have the potential to cause acute interstitial nephritis • 4. Neurotoxicity – the penicillins are irritating to neuronal tissue, and they can provoke seizures • 5. Hematologic toxicities- decreased coagulation may be observed with the antipseudomonal penicillins (carbenicillin and ticarcillin) and to some extent penicillin G • - additional toxicities include eosinophilia
  • 24. • 6. Cation toxicity – penicillins are generally administered as the sodium or potassium salt. • - toxicities may be caused by the large quantities of sodium or potassium that accompany the penicillin
  • 25. CEPHALOSPORINS • The cephalosporins are beta lactam antibiotics that are closely related both structurally and functionally to the penicillins • They have the same mode of actions of penicillins, and they are affected by the same resistance mechanisms • They tend to be more resistant than the penicillins to certain beta lactamases
  • 26. CEPHALOSPORINS • 5th Gen • Ceftobiprole (Teflaro) • Ceftaroline(Zeftera) • 1st Gen • Cefadroxil • Cefazolin (Ilozef) • Cephalexin (Cefalin/Ivynall) • Cefalotin • Ceftradine • 2nd Gen • Cefaclor (Ceclor) • Cefprozil • Cefuroxime (Cefurex) • Cefoxitin • Cefamandole • Cefmetazole • Lefotiam • 3rd Gen • Cefdinir • Cefixime • Cefotaxime • Ceftazidime • Ceftibuten • Ceftizoxime • Ceftriaxone (Keptrix) • Cefoperazone • Cefpodoxime • 4th Gen • Cefipime (Polyzef) • Cefpirome
  • 27. ANTIBACTERIAL SPECTRUM • They have been classified as 1st, 2nd, 3rd, 4th and 5th generation, based largely on their bacterial susceptibility patterns and resistance to beta lactamase • Ineffective against MRSA, L. monocytogenes, Clostridium difficile, and the enterococci
  • 28. • First generation – act as penicillin G substitutes • - resistant to Staphylococcal penicillinase and also have activity against Proteus mirabillis, E. Coli, and Klebsiella pneumoniae • Second generation – display greater activity against three additional gram negative organisms: H. influenza, Enterobacter aerogenes and some Neisseria species, whereas activity against gram positive organisms is weaker
  • 29. • Third generation – assumed an important role in the treatment of infectious disease • - inferior to first-generation cephalosporins in regard to their activity against gram positive cocci, the third- generation cephalosporins have enhanced activity gram negative bacilli • Fourth generation – Cefepime – is classified as fourth generation and must be administered parenterally • - effective against aerobic gram negative organisms such as Enterobater, E. coli, K. pneumonia, P. mirabilis, P, aeruginosa
  • 30. RESISTANCE • Mechanisms of bacterial resistance to the cephalosporins are essentially the same sas those described for the penicillins • 5th generation – Ceftobiprole can be distinguished from other beta lactams by its increased binding to penicillin-binding protein 2a, enzyme most directly related to methicillin-resistant staphylococci • Coverage is from gram negative to gram positives, MRSA and including Pseudomonas species • Against both the community acquired MRSA strains and hospital-acquired MRSA strains
  • 31. PHARMAKOKINETICS • Administration • Cephalosporins are administered IM or IV because of their poor oral absorption • Distributions • Cephalosporins distribute very well into the body fluids • Ceftriaxone or cefoxatime are effective in the treatment of neonatal and childhood meningitis caused by H. influenza • Cefazolin finds application as a single prophylaxis dose prior to surgery because of its 1.8 hour half-life and its activity against penicillinase-producing S. aureus
  • 32. • Fate • Elimination occurs though tubular secretion and/or glomerular filtration • Doses must be adjusted in cases of severe renal failure to guard against accumulation and toxicity • Ceftriaxone is excreted through the bile into the feces and, therefore is frequently employed in patients with renal insufficiency • Adverse effects • Allergic manifestations – patients who have had anaphylactic reponse to penicillins should not receive cephalosporins
  • 33. OTHER BETA LACTAM ANTIBIOTICS • Carbapenems- synthetic beta lactam antibiotics that differ in structure from the penicillins in that the sulfur atom of the thiazolidine ring has been externalized and replaced by a carbon atom • Imipenem, Meropinem and Ertapenem are the only drugs of this group currently available • Imipenem is compounded with cilastatin to protect it from metabolism by renal dehydropeptidase
  • 34. ANTIBACTERIAL SPECTRUM • Imipinem/cilastatin and meropenem are the broadest spectrum beta lactam antibiotic preparations currently available • Imipenem (Tienam,Plastin)- resists hydrolysis by most beta lactamases, but not metallo-beta lactamases • Meropenem (Merop) has antibacterial activity similar to that of imipenem • Ertapenem is not an alternative for P. aeruginosa coverage, because most exhibit resistance
  • 35. PHARMAKOKINETICS • Imipenem and meropenem are administered IV and penetrate well into body tissues and fluids, including the CSF when the minges are inflamed. They are excreted through glomerular filtration • Imipenem undergoes cleavage by by dehydropeptidase found in the brush border of the proximal renal tubule • Compounding the imipenem with cilastatin protects the parent drug and, thus, prevents the formation of the toxic metabolite • Meropenem does not undergo metabolism • Ertapenem can be administeres via IV or IM
  • 36. ADVERSE AFFECTS • Imipenem/cilastatin can cause nausea, vomiting and diarrhea • Eosinophilia and neutropenia are less common than with other beta lactams
  • 37. MONOBACTAMS • The monobactams, which also disrupt bacterial cell wall synthesis, are unique, because the B-lactam ring is not fused to another ring. • Aztreonam (Aztram), which is the only commercially available monobactam, has antimicrobial activity directed primarily against the enterobacteriaceae, but also acts against aerobic gram-negative rods, including P. aeruginosa.
  • 38. B-LACTAMASE INHIBITORS • Hydrolysis of the B-lactam ring, either by enzymatic cleavage with a B-lactamase or by acid, destroys the antimicrobial activity of a B-lactam antibiotic. • B-Lactamase inhibitors, such as clavulanic acid, sulbactam, and tazobactam, contain a B-lactam ring but, by themselves, do not have significant antibacterial activity.
  • 39. VANCOMYCIN • Vancomycin is a tricyclic glycopeptide that has become increasingly important because of it effectiveness against multiple drug-resistant organisms, such as MRSA and enterococci.
  • 40. MODE OF ACTION • Vancomycin inhibits synthesis of bacterial cell wall phospholipids as well as peptidoglycan polymerization by binding to the D-Ala-D-Ala side chain of the precursor pentapeptide. This prevents the transglycosylation step in peptidoglycan polymerization, thus weakening the cell wall and damaging the underlying cell membrane.
  • 41. ANTIBACTERIAL SPECTRUM • Vancomycin is effective primarily against gram-positive organisms. It has been lifesaving in the treatment of MRSA and methicillin-resistant Staphylococcus epidermidis infections as well as enterococcal infections.
  • 42. RESISTANCE • Vancomycin resistance can be caused by plasmid-mediated change in permeability to the drug or by decreased binding of vancomycin to receptor molecules.
  • 43. PHARMACOKINETICS • Slow IV infusion is employed for treatment of systemic infections or for prophylaxis. Because vancomycin is not absorbed after oral administration, this route is employed only for the treatment of antibiotic-induced colitis due to C. difficile when metronidazole has proven to be ineffective. • Inflammation allows penetration into the meninges.
  • 44. ADVERSE EFFECTS • Side effects are a serious problem with vancomycin and include fever, chills, and/or phlebitis at the infusion site. • Flushing and shock results from histamine release associated with a rapid infusion.
  • 45. DAPTOMYCIN • Daptomycin is a cyclic lipopeptide antibiotic that is an alternative to other agents, such as linezolid and quinupristin/ dalfopristin, for treating infections caused by resistant gram-positive organisms, including MRSA and vancomycin-resistant enterococci.
  • 46. MODE OF ACTION • Upon binding to the bacterial cytoplasmic membrane, daptomycin induces rapid depolarization of the membrane, thus disrupting multiple aspects of membrane function and inhibiting intracellular synthesis of DNA, RNA, and protein. • Daptomycin is bactericidal, and bacterial killing is concentration dependent.
  • 47. ANTIBACTERIAL SPECTRUM • Daptomycin has a spectrum of activity limited to gram-positive organisms, which includes methicillin-susceptible and methicillin-resistant S.aureus, penicillin-resistant Streptococcus pneumonia, Streptococcus pyogenes, Corynebacterium jeikeium, E. faecalis, and E. faecium.
  • 48. PHARMACOKINETICS • Daptomycin is 90 to 95 percent protein bound and does not appear to undergo hepatic metabolism; however, the dosing interval needs to be adjusted in patients with renal impairment. • In skin and soft tissue infections, daptomycin is administered at 4 mg/kg IV daily via a 30-minute infusion. Nevertheless, when treating bacteremia and endocarditis, dose should be increased to 6 mg/kg.
  • 49. ADVERSE EFFECTS • The most common adverse effects reported in clinical trials included constipation, nausea, headache, and insomnia. • Increased hepatic transaminases and also elevations in creatin phosphokinases occurred, suggesting weekly monitoring while the patient is receiving daptomycin.

Notas del editor

  1. No effect on bacteria that are not growing and dividing
  2. The nature of this side chain affects the antimicrobial spectrum, stability to the stomach acid and susceptibility to bacterial degradative enzymes (B-lactamase)
  3. Cell lysis- process of disintegration or dissolution autolysis- breakdown of all or part of the cell by self-produced enzymes